Literature DB >> 27044455

Venous gas emboli detected by two-dimensional echocardiography are an imperfect surrogate endpoint for decompression sickness.

David J Doolette1.   

Abstract

INTRODUCTION: In studies of decompression procedures, ultrasonically detected venous gas emboli (VGE) are commonly used as a surrogate endpoint for decompression sickness (DCS). However, VGE have not been rigorously validated as a surrogate endpoint for DCS.
METHODS: A data set for validation of VGE as a surrogate endpoint for DCS was retrospectively assembled comprising maximum VGE grades measured using two-dimensional echocardiography and DCS outcome following 868 laboratory man-dives. Dives were conducted according to only ten different experimental interventions such that the ten cumulative incidences of DCS (0-22%) provide relatively precise point estimates of the probability of DCS, P(DCS). Logistic models relating the P(DCS) to VGE grade and intervention were fitted to these validation data. Assessment of the models was used to evaluate the Prentice criteria for validating a surrogate endpoint.
RESULTS: The P(DCS)) increased with increasing VGE grade. However, the difference in the P(DCS) between interventions was larger than explained by differences in VGE grades. Therefore, VGE grades did not largely capture the intervention effect on the true endpoint (DCS) in accord with the Prentice definition of a surrogate endpoint.
CONCLUSIONS: VGE can be used for comparisons of decompression procedures in samples of subjects but must be interpreted cautiously. A significant difference in VGE grade probably indicates a difference in the P(DCS). However, failure to find a significant difference in VGE grades does not necessarily indicate no difference in P(DCS).

Entities:  

Keywords:  Venous gas emboli; decompression; decompression sickness; diving; echocardiography; research; statistics

Mesh:

Year:  2016        PMID: 27044455

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  6 in total

1.  Comparison of Newer Hand-Held Ultrasound Devices for Post-Dive Venous gas Emboli Quantification to Standard Echocardiography.

Authors:  Kamellia Karimpour; Rhiannon J Brenner; Grant Z Dong; Jayne Cleve; Stefanie Martina; Catherine Harris; Gabriel J Graf; Benjamin J Kistler; Andrew H Hoang; Olivia Jackson; Virginie Papadopoulou; Frauke Tillmans
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

2.  Bubbles Quantified In vivo by Ultrasound Relates to Amount of Gas Detected Post-mortem in Rabbits Decompressed from High Pressure.

Authors:  Yara Bernaldo de Quirós; Andreas Møllerløkken; Marianne B Havnes; Alf O Brubakk; Oscar González-Díaz; Antonio Fernández
Journal:  Front Physiol       Date:  2016-07-21       Impact factor: 4.566

3.  Association Between Heart Rate Variability and Decompression-Induced Physiological Stress.

Authors:  Sergio Rhein Schirato; Ingrid El-Dash; Vivian El-Dash; Bruna Bizzarro; Alessandro Marroni; Massimo Pieri; Danilo Cialoni; José Guilherme Chaui-Berlinck
Journal:  Front Physiol       Date:  2020-07-03       Impact factor: 4.566

4.  Physiology of repeated mixed gas 100-m wreck dives using a closed-circuit rebreather: a field bubble study.

Authors:  Costantino Balestra; François Guerrero; Pierre Lafère; Sigrid Theunissen; Peter Germonpré
Journal:  Eur J Appl Physiol       Date:  2021-11-28       Impact factor: 3.078

5.  Hyperbaric exposure in rodents with non-invasive imaging assessment of decompression bubbles: A scoping review protocol.

Authors:  Joshua Currens; Paul A Dayton; Peter Buzzacott; Virginie Papadopoulou
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

6.  The impact of different gas mixtures on inflammatory responses in advanced recreational divers.

Authors:  Monica Rocco; Luigi Maggi; Chiara Loffredo; Massimiliano Pelli; Pia Di Benedetto; Silvia Fiorelli; Maurizio Simmaco; Roberto Alberto De Blasi
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.